{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:17:51Z","timestamp":1790144271206,"version":"4.0.1"},"reference-count":83,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.bmcl.2020.126965","type":"journal-article","created":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T02:15:41Z","timestamp":1578708941000},"page":"126965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Inhibitors of the Zika virus protease NS2B-NS3"],"prefix":"10.1016","volume":"30","author":[{"given":"Saan","family":"Voss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3704-2699","authenticated-orcid":false,"given":"Christoph","family":"Nitsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2020.126965_b0005","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMra1808246","article-title":"Zika virus infection \u2013 after the pandemic","volume":"381","author":"Musso","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2020.126965_b0010","unstructured":"WHO Region of the Americas\/Pan American Health Organization. PLISA Health Information Platform for the Americas: Cases of Zika virus disease, by country or territory; accessed November 2019, http:\/\/www.paho.org\/data\/index.php\/en\/mnu-topics\/zika\/524-zika-weekly-en.html."},{"key":"10.1016\/j.bmcl.2020.126965_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007213","article-title":"Global expansion and redistribution of Aedes-borne virus transmission risk with climate change","volume":"13","author":"Ryan","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"4 Suppl.","key":"10.1016\/j.bmcl.2020.126965_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2149\/tmh.2011-S05","article-title":"Dengue, urbanization and globalization: the unholy trinity of the 21st century","volume":"39","author":"Gubler","year":"2011","journal-title":"Trop Med Health"},{"key":"10.1016\/j.bmcl.2020.126965_b0025","unstructured":"World Health Organization, Zika epidemiology update; version July 2019."},{"key":"10.1016\/j.bmcl.2020.126965_b0030","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMoa1709481","article-title":"Pregnancy outcomes after ZIKV infection in French territories in the Americas","volume":"378","author":"Hoen","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2020.126965_b0035","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1056\/NEJMoa1602412","article-title":"Zika virus infection in pregnant women in Rio de Janeiro","volume":"375","author":"Brasil","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2020.126965_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002203","article-title":"Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barr\u00e9 syndrome: systematic review","volume":"14","author":"Krauer","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.bmcl.2020.126965_b0045","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barr\u00e9 syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2020.126965_b0050","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1605564","article-title":"Guillain-Barr\u00e9 syndrome associated with Zika virus infection in Colombia","volume":"375","author":"Parra","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2020.126965_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2019.197770","article-title":"Flavivirus infection \u2013 a review of immunopathogenesis, immunological response, and immunodiagnosis","volume":"274","author":"Chong","year":"2019","journal-title":"Virus Res"},{"key":"10.1016\/j.bmcl.2020.126965_b0060","doi-asserted-by":"crossref","first-page":"206","DOI":"10.15252\/embr.201745302","article-title":"The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design","volume":"19","author":"Rey","year":"2018","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bmcl.2020.126965_b0065","first-page":"781","article-title":"Dengue virus-specific antibodies enhance Brazilian Zika virus infection","volume":"215","author":"Castanha","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bmcl.2020.126965_b0070","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni.3515","article-title":"Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus","volume":"17","author":"Dejnirattisai","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bmcl.2020.126965_b0075","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1073\/pnas.1607931113","article-title":"Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus","volume":"113","author":"Priyamvada","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2020.126965_b0080","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2020.126965_b0085","doi-asserted-by":"crossref","first-page":"15674","DOI":"10.1038\/ncomms15674","article-title":"Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus","volume":"8","author":"Pantoja","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2020.126965_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006487","article-title":"Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques","volume":"13","author":"McCracken","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bmcl.2020.126965_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007766","article-title":"Primary infection with dengue or Zika virus does not affect the severity of heterologous secondary infection in macaques","volume":"15","author":"Breitbach","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bmcl.2020.126965_b0100","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.1038\/s41598-017-10901-1","article-title":"Prior exposure to Zika virus significantly enhances peak dengue-2 viremia in rhesus macaques","volume":"7","author":"George","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2020.126965_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007640","article-title":"The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis","volume":"15","author":"Langerak","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bmcl.2020.126965_b0110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aal4365","article-title":"Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity","volume":"356","author":"Bardina","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2020.126965_b0115","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/S1473-3099(18)30063-X","article-title":"Development of vaccines against Zika virus","volume":"18","author":"Poland","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmcl.2020.126965_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007695","article-title":"Anti-ganglioside antibodies in patients with Zika virus infection-associated Guillain-Barr\u00e9 syndrome in Brazil","volume":"13","author":"Rivera-Correa","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmcl.2020.126965_b0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/infdis\/jiy466","article-title":"Augmented Zika and dengue neutralizing antibodies are associated with Guillain-Barr\u00e9 syndrome","volume":"219","author":"Lynch","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bmcl.2020.126965_b0130","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.autrev.2016.03.020","article-title":"Zika virus and autoimmunity: from microcephaly to Guillain-Barr\u00e9 syndrome, and beyond","volume":"15","author":"Lucchese","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.bmcl.2020.126965_b0135","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0140-6736(17)33105-7","article-title":"Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials","volume":"391","author":"Gaudinski","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2020.126965_b0140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-med-040717-051127","article-title":"Zika virus vaccine development: progress in the face of new challenges","volume":"70","author":"Diamond","year":"2019","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.bmcl.2020.126965_b0145","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12916-018-1067-x","article-title":"Zika vaccines and therapeutics: landscape analysis and challenges ahead","volume":"16","author":"Wilder-Smith","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.bmcl.2020.126965_b0150","article-title":"Drugs for the treatment of Zika virus infection","author":"Bernatchez","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2020.126965_b0155","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrd.2017.33","article-title":"Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond","volume":"16","author":"Boldescu","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2020.126965_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.02725","article-title":"Development of small-molecule inhibitors against Zika virus infection","volume":"10","author":"Wang","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmcl.2020.126965_b0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-981-10-8727-1_13","article-title":"Strategies towards protease inhibitors for emerging flaviviruses","volume":"1062","author":"Nitsche","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.bmcl.2020.126965_b0170","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12551-019-00508-3","article-title":"Proteases from dengue, West Nile and Zika viruses as drug targets","volume":"11","author":"Nitsche","year":"2019","journal-title":"Biophys Rev"},{"key":"10.1016\/j.bmcl.2020.126965_b0175","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.tim.2017.07.001","article-title":"Zika virus protease: an antiviral drug target","volume":"25","author":"Kang","year":"2017","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.bmcl.2020.126965_b0180","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.antiviral.2015.03.014","article-title":"The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development","volume":"118","author":"Luo","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2020.126965_b0185","doi-asserted-by":"crossref","first-page":"11348","DOI":"10.1021\/cr500233q","article-title":"Biochemistry and medicinal chemistry of the dengue virus protease","volume":"114","author":"Nitsche","year":"2014","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2020.126965_b0190","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1021\/acs.chemrev.7b00719","article-title":"Biochemistry and molecular biology of flaviviruses","volume":"118","author":"Barrows","year":"2018","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2020.126965_b0195","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1021\/acs.jmedchem.5b01697","article-title":"Recent progress in the development of HIV-1 protease inhibitors for the treatment of HIV\/AIDS","volume":"59","author":"Ghosh","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2020.126965_b0200","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/14656566.2018.1454428","article-title":"Protease inhibitor therapy for hepatitis C virus-infection","volume":"19","author":"de Leuw","year":"2018","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bmcl.2020.126965_b0205","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.15252\/embj.201695871","article-title":"Zika virus NS1, a pathogenicity factor with many faces","volume":"35","author":"Hilgenfeld","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.bmcl.2020.126965_b0210","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1038\/emboj.2008.232","article-title":"Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein","volume":"27","author":"Luo","year":"2008","journal-title":"EMBO J"},{"key":"10.1016\/j.bmcl.2020.126965_b0215","doi-asserted-by":"crossref","first-page":"14762","DOI":"10.1038\/ncomms14762","article-title":"Structure and function of the Zika virus full-length NS5 protein","volume":"8","author":"Zhao","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2020.126965_b0220","first-page":"E376","article-title":"Characterization of cytopathic factors through genome-wide analysis of the Zika viral proteins in fission yeast","volume":"114","author":"Li","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2020.126965_b0225","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/22221751.2019.1598291","article-title":"Genetic and biochemical characterizations of Zika virus NS2A protein","volume":"8","author":"Zhang","year":"2019","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.bmcl.2020.126965_b0230","doi-asserted-by":"crossref","first-page":"e02375","DOI":"10.1128\/mBio.02375-19","article-title":"Zika virus NS2A-mediated virion assembly","volume":"10","author":"Zhang","year":"2019","journal-title":"MBio"},{"issue":"5","key":"10.1016\/j.bmcl.2020.126965_b0235","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.stem.2016.07.019","article-title":"Zika virus NS4A and NS4B proteins deregulate Akt-mTOR signaling in human fetal neural stem cells to inhibit neurogenesis and induce autophagy","volume":"19","author":"Liang","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bmcl.2020.126965_b0240","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-291X(67)80055-X","article-title":"On the size of the active site in proteases. I. Papain","volume":"27","author":"Schechter","year":"1967","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmcl.2020.126965_b0245","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1101\/gr.849004","article-title":"WebLogo: a sequence logo generator","volume":"14","author":"Crooks","year":"2004","journal-title":"Genome Res"},{"key":"10.1016\/j.bmcl.2020.126965_b0250","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1016\/j.bmc.2019.07.038","article-title":"Peptide derivatives as inhibitors of NS2B-NS3 protease from dengue, West Nile, and Zika flaviviruses","volume":"27","author":"da Silva-J\u00fanior","year":"2019","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2020.126965_b0255","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1126\/science.aag2419","article-title":"Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor","volume":"353","author":"Lei","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2020.126965_b0260","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1021\/acs.jmedchem.6b01021","article-title":"Peptide-boronic acid inhibitors of flaviviral proteases: medicinal chemistry and structural biology","volume":"60","author":"Nitsche","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2020.126965_b0265","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.str.2017.06.006","article-title":"Structural dynamics of Zika virus NS2B-NS3 protease binding to dipeptide inhibitors","volume":"25","author":"Li","year":"2017","journal-title":"Structure"},{"key":"10.1016\/j.bmcl.2020.126965_b0270","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.str.2018.02.005","article-title":"Structural insights into the inhibition of Zika virus NS2B-NS3 protease by a small-molecule inhibitor","volume":"26","author":"Li","year":"2018","journal-title":"Structure"},{"key":"10.1016\/j.bmcl.2020.126965_b0275","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.antiviral.2017.03.011","article-title":"Solution conformations of a linked construct of the Zika virus NS2B-NS3 protease","volume":"142","author":"Mahawaththa","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2020.126965_b0280","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2018.10.006","article-title":"Structures of Zika virus NS2B-NS3 protease in complex with peptidomimetic inhibitors","volume":"160","author":"Phoo","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2020.126965_b0285","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1080\/14756366.2017.1306521","article-title":"Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication","volume":"32","author":"Kouretova","year":"2017","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmcl.2020.126965_b0290","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.antiviral.2016.12.018","article-title":"Extended substrate specificity and first potent irreversible inhibitor\/activity-based probe design for Zika virus NS2B-NS3 protease","volume":"139","author":"Rut","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2020.126965_b0295","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1021\/acs.orglett.9b01545","article-title":"Biocompatible macrocyclization between cysteine and 2-cyanopyridine generates stable peptide inhibitors","volume":"21","author":"Nitsche","year":"2019","journal-title":"Org Lett"},{"key":"10.1016\/j.bmcl.2020.126965_b0300","doi-asserted-by":"crossref","first-page":"12357","DOI":"10.1039\/C8CC07448H","article-title":"Broad-spectrum catalytic metallopeptide inactivators of Zika and West Nile virus NS2B-NS3 proteases","volume":"54","author":"Pinkham","year":"2018","journal-title":"Chem Commun"},{"key":"10.1016\/j.bmcl.2020.126965_b0305","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1021\/acsmedchemlett.8b00535","article-title":"De novo discovery of nonstandard macrocyclic peptides as noncompetitive inhibitors of the Zika virus NS2B-NS3 protease","volume":"10","author":"Nitsche","year":"2019","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2020.126965_b0310","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3390\/toxins11100584","article-title":"An antiviral peptide from Alopecosa nagpag spider targets NS2B-NS3 protease of flaviviruses","volume":"11","author":"Ji","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.bmcl.2020.126965_b0315","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1021\/jm300655h","article-title":"Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease","volume":"55","author":"Xu","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2020.126965_b0320","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1126\/science.aai9309","article-title":"Crystal structure of unlinked NS2B-NS3 protease from Zika virus","volume":"354","author":"Zhang","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2020.126965_b0325","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.antiviral.2016.12.016","article-title":"Identification of novel small molecule inhibitors against NS2B-NS3 serine protease from Zika virus","volume":"139","author":"Lee","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2020.126965_b0330","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ejmech.2019.07.007","article-title":"Cell-active carbazole derivatives as inhibitors of the Zika virus protease","volume":"180","author":"Rassias","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2020.126965_b0335","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1021\/jacs.9b02505","article-title":"Discovery, X-ray crystallography and antiviral activity of allosteric inhibitors of flavivirus NS2B-NS3 protease","volume":"141","author":"Yao","year":"2019","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2020.126965_b0340","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1021\/acs.jmedchem.9b01697","article-title":"Proline-based allosteric inhibitors of Zika and dengue virus NS2B\/NS3 proteases","volume":"62","author":"Millies","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2020.126965_b0345","unstructured":"Grinter R. [ccp4bb] Questionable Ligand Density: 6MO0, 6MO1, 6MO2. 19 July 2019; accessed January 2020, https:\/\/www.mail-archive.com\/ccp4bb@jiscmail.ac.uk\/msg47072.html."},{"key":"10.1016\/j.bmcl.2020.126965_b0350","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/AAC.03543-14","article-title":"Novel dengue virus NS2B\/NS3 protease inhibitors","volume":"59","author":"Wu","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2020.126965_b0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006411","article-title":"A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease","volume":"13","author":"Brecher","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bmcl.2020.126965_b0360","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.antiviral.2017.04.015","article-title":"Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists","volume":"143","author":"Shiryaev","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2020.126965_b0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180632","article-title":"Solution conformations of Zika NS2B-NS3pro and its inhibition by natural products from edible plants","volume":"12","author":"Roy","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmcl.2020.126965_b0370","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.antiviral.2017.02.002","article-title":"Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor","volume":"141","author":"Chan","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2020.126965_b0375","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.antiviral.2017.07.007","article-title":"Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo","volume":"145","author":"Yuan","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2020.126965_b0380","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/cr.2017.88","article-title":"Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction","volume":"27","author":"Li","year":"2017","journal-title":"Cell Res"},{"key":"10.1016\/j.bmcl.2020.126965_b0385","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.antiviral.2017.12.018","article-title":"Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease","volume":"150","author":"Li","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2020.126965_b0390","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.antiviral.2017.04.016","article-title":"Suramin inhibits Zika virus replication by interfering with virus attachment and release of infectious particles","volume":"143","author":"Albulescu","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2020.126965_b0395","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.antiviral.2018.10.019","article-title":"Zika virus NS2B-NS3 proteinase: a new target for an old drug \u2013 suramin a lead compound for NS2B-NS3 proteinase inhibition","volume":"160","author":"Coronado","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2020.126965_b0400","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.antiviral.2017.04.017","article-title":"Polysulfonate suramin inhibits Zika virus infection","volume":"143","author":"Tan","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2020.126965_b0405","doi-asserted-by":"crossref","first-page":"18132","DOI":"10.1021\/acsomega.8b01002","article-title":"Hydroxychloroquine inhibits Zika virus NS2B-NS3 protease","volume":"3","author":"Kumar","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmcl.2020.126965_b0410","first-page":"1","article-title":"Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease","author":"Akaberi","year":"2019","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmcl.2020.126965_b0415","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10529-016-2261-6","article-title":"Inhibitory effect of flavonoids against NS2B-NS3 protease of Zika virus and their structure activity relationship","volume":"39","author":"Lim","year":"2017","journal-title":"Biotechnol Lett"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20300184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20300184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:32:38Z","timestamp":1760772758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X20300184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0960894X20300184"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.126965","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitors of the Zika virus protease NS2B-NS3","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.126965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"126965"}}